Cassava Sciences, Inc.
(NASDAQ: SAVA)

Cassava Sciences, Inc. engages in the development of novel drugs and diagnostics. It focuses on developing product candidates intended for the treatment of Alzheimer’s disease, including PTI-125 and PTI-125Dx. The company was founded by Remi Barbier in May 1998 and is headquartered in Austin, TX.

1.955 -

-0.035 (-1.76%)
Jarak 1.950 - 2.030   (4.10%)
Buka 1.970
Tutup Terdahulu 1.990
Harga Beli -
Beli Purata -
Jual Beli -
Purata Jual -
Purata 258,479
Nilai 3,509,459
Catatan -
Harga tertunda. Dikemas kini pada 17 Mar 2026 03:59.
Data dikuasakan oleh
Lihat Semua Acara
Please login to view stock data and analysis